Using D-cycloserine to Enhance the Benefits of Cognitive Behavioral Therapy for Schizophrenia
NCT00742079
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
D-cycloserine
BEHAVIORAL:
Cognitive Behavioral Therapy
Sponsor
Massachusetts General Hospital
Collaborators
[object Object]